Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20038030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048589HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20026706HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048288HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20033039HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20021233HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20032030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44018639HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021744HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44029331HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00458
Drug NameImipramine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs7855217
CitationsCusack B, Nelson A, Richelson E: Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl). 1994 May;114(4):559-65.
GroupsApproved
Direct ClassificationDibenzazepines
SMILESCN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12
PathwaysImipramine Metabolism Pathway; Imipramine Action Pathway
PharmGKBPA449969
ChEMBLCHEMBL11